DNA methylation in demyelinated multiple sclerosis hippocampus


Multiple Sclerosis (MS) is an immune-mediated demyelinating disease of the human central nervous system (CNS). Memory impairments and hippocampal demyelination are common features in MS patients. Our previous data have shown that demyelination alters neuronal gene expression in the hippocampus. DNA methylation is a common epigenetic modifier of gene expression. In this study, we investigated whether DNA methylation is altered in MS hippocampus following demyelination. Our results show that mRNA levels of DNA methyltransferase were increased in demyelinated MS hippocampus, while de-methylation enzymes were decreased. Comparative methylation profiling identify hypo-methylation within upstream sequences of 6 genes and hyper-methylation of 10 genes in demyelinated MS hippocampus. Genes identified in the current study were also validated in an independent microarray dataset generated from MS hippocampus. Independent validation using RT-PCR revealed that DNA methylation inversely correlated with mRNA levels of the candidate genes. Queries across cell-specific databases revealed that a majority of the candidate genes are expressed by astrocytes and neurons in mouse and human CNS. Taken together, our results expands the list of genes previously identified in MS hippocampus and establish DNA methylation as a mechanism of altered gene expression in MS hippocampus.

DOI: 10.1038/s41598-017-08623-5

7 Figures and Tables

Cite this paper

@inproceedings{Chomyk2017DNAMI, title={DNA methylation in demyelinated multiple sclerosis hippocampus}, author={Anthony M. Chomyk and Christina M. Volsko and Ajai K. Tripathi and Sadie A. Deckard and Bruce D Trapp and Robert Fox and Ranjan Dutta}, booktitle={Scientific reports}, year={2017} }